DE CATERINA, RAFFAELE Statistiche
DE CATERINA, RAFFAELE
DIPARTIMENTO DI PATOLOGIA CHIRURGICA, MEDICA, MOLECOLARE E DELL'AREA CRITICA
Aspirin hypersensitivity: a practical guide for cardiologists
2024-01-01 Grimaldi, Silvia; Migliorini, Paola; Puxeddu, Ilaria; Rossini, Roberta; DE CATERINA, Raffaele
Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
2024-01-01 Mattii, L.; Moscato, S.; Ippolito, C.; Polizzi, E.; Novo, G.; Zucchi, R.; De Caterina, R.; Ghelardoni, S.; Madonna, R.
Inferior vena cava filters: Concept review and summary of current guidelines
2024-01-01 Visconti, Luca; Celi, Alessandro; Carrozzi, Laura; Tinelli, Camilla; Crocetti, Laura; Daviddi, Francesco; De Caterina, Raffaele; Madonna, Rosalinda; Pancani, Roberta
Prognostic impact of peripheral artery disease-related parameters in patients with acute coronary syndrome
2024-01-01 Masini, Gabriele; Gargani, Luna; Morizzo, Carmela; Guarini, Giacinta; Bort, Ida Rebecca; Baldini, Matteo; Tamborrino, Pietro Paolo; Vitale, Carlo; Palombo, Carlo; De Caterina, Raffaele
Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis
2024-01-01 Madonna, R.; Barachini, S.; Ghelardoni, S.; Lu, L.; Shen, W. -F.; De Caterina, R.
A highly-detailed anatomical study of left atrial auricle as revealed by in-vivo computed tomography
2023-01-01 Mantini, C.; Corradi, F.; Ricci, F.; Jensen, B.; Tana, C.; Di Mascio, V.; Mastrodicasa, D.; Bucciarelli, B.; Procaccini, L.; Saba, L.; Marco, Tana; Cademartiri, F.; De Caterina, R.
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma
2023-01-01 Meloni, Antonella; Gargani, Luna; Bruni, Cosimo; Cavallaro, Camilla; Gobbo, Marco; D'Agostino, Andreina; D'Angelo, Gennaro; Martini, Nicola; Grigioni, Francesco; Sinagra, Gianfranco; De Caterina, Raffaele; Quaia, Emilio; Mavrogeni, Sophie; Cademartiri, Filippo; Matucci-Cerinic, Marco; Pepe, Alessia
Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative
2023-01-01 Catapano, A. L.; De Caterina, R.; Jukema, J. W.; Klempfner, R.; Landmesser, U.; Schiele, F.; Sionis, A.
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases
2023-01-01 De Carlo, M.; Schlager, O.; Mazzolai, L.; Brodmann, M.; Espinola-Klein, C.; Staub, D.; Aboyans, V.; Sillesen, H.; Debus, S.; Venermo, M.; Belch, J.; Ferrari, M.; De Caterina, R.
Declining trends of premature mortality from ischemic heart disease and regional differences in Italy from 2011 to 2017
2023-01-01 Zuin, M.; di Fusco, S. A.; De Caterina, R.; Roncon, L.; Rigatelli, G.; Colivicchi, F.; Bilato, C.
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications
2023-01-01 Galli, M.; Franchi, F.; Rollini, F.; Ortega-Paz, L.; D'Amario, D.; De Caterina, R.; Mehran, R.; Gibson, C. M.; Angiolillo, D. J.
Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial
2023-01-01 Shim, C. Y.; Seo, J.; Kim, Y. J.; Lee, S. H.; De Caterina, R.; Lee, S.; Hong, G. -R.; Lee, C. J.; Shin, D. -H.; Ha, J. -W.; Suh, Y. J.; Choi, J. Y.; Cho, I. -J.; Roh, Y. H.
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy
2023-01-01 Madonna, Rosalinda; Moscato, Stefania; Cufaro, Maria Concetta; Pieragostino, Damiana; Mattii, Letizia; Del Boccio, Piero; Ghelardoni, Sandra; Zucchi, Riccardo; De Caterina, Raffaele
Factor XI inhibitors: cardiovascular perspectives
2023-01-01 De Caterina, Raffaele; Prisco, Domenico; Eikelboom, John W
Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives
2023-01-01 Corradi, Francesco; Masini, Gabriele; Bucciarelli, Tonino; DE CATERINA, Raffaele
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
2023-01-01 Liga, Riccardo; Colli, Andrea; Taggart, David P; Boden, William E; De Caterina, Raffaele
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
2023-01-01 Potere, N.; Garrad, E.; Kanthi, Y.; Di Nisio, M.; Kaplanski, G.; Bonaventura, A.; Connors, J. M.; De Caterina, R.; Abbate, A.
Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry
2023-01-01 Schnabel, R. B.; Ameri, P.; Siller-Matula, J. M.; Diemberger, I.; Gwechenberger, M.; Pecen, L.; Manu, M. C.; Souza, J.; De Caterina, R.; Kirchhof, P.
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis
2023-01-01 Galli, M; Benenati, S; Zito, A; Capodanno, D; Zoccai, Gb; Ortega-Paz, L; Iaconelli, A; D'Amario, D; Porto, I; Burzotta, F; Trani, C; De Caterina, R; Gaudino, M; Escaned, J; Angiolillo, Dj; Crea, F
Reversal agents for current and forthcoming direct oral anticoagulants
2023-01-01 van Es, N.; De Caterina, R.; Weitz, J. I.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Aspirin hypersensitivity: a practical guide for cardiologists | 1-gen-2024 | Grimaldi, Silvia; Migliorini, Paola; Puxeddu, Ilaria; Rossini, Roberta; DE CATERINA, Raffaele | |
Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway | 1-gen-2024 | Mattii, L.; Moscato, S.; Ippolito, C.; Polizzi, E.; Novo, G.; Zucchi, R.; De Caterina, R.; Ghelardoni, S.; Madonna, R. | |
Inferior vena cava filters: Concept review and summary of current guidelines | 1-gen-2024 | Visconti, Luca; Celi, Alessandro; Carrozzi, Laura; Tinelli, Camilla; Crocetti, Laura; Daviddi, Francesco; De Caterina, Raffaele; Madonna, Rosalinda; Pancani, Roberta | |
Prognostic impact of peripheral artery disease-related parameters in patients with acute coronary syndrome | 1-gen-2024 | Masini, Gabriele; Gargani, Luna; Morizzo, Carmela; Guarini, Giacinta; Bort, Ida Rebecca; Baldini, Matteo; Tamborrino, Pietro Paolo; Vitale, Carlo; Palombo, Carlo; De Caterina, Raffaele | |
Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis | 1-gen-2024 | Madonna, R.; Barachini, S.; Ghelardoni, S.; Lu, L.; Shen, W. -F.; De Caterina, R. | |
A highly-detailed anatomical study of left atrial auricle as revealed by in-vivo computed tomography | 1-gen-2023 | Mantini, C.; Corradi, F.; Ricci, F.; Jensen, B.; Tana, C.; Di Mascio, V.; Mastrodicasa, D.; Bucciarelli, B.; Procaccini, L.; Saba, L.; Marco, Tana; Cademartiri, F.; De Caterina, R. | |
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma | 1-gen-2023 | Meloni, Antonella; Gargani, Luna; Bruni, Cosimo; Cavallaro, Camilla; Gobbo, Marco; D'Agostino, Andreina; D'Angelo, Gennaro; Martini, Nicola; Grigioni, Francesco; Sinagra, Gianfranco; De Caterina, Raffaele; Quaia, Emilio; Mavrogeni, Sophie; Cademartiri, Filippo; Matucci-Cerinic, Marco; Pepe, Alessia | |
Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative | 1-gen-2023 | Catapano, A. L.; De Caterina, R.; Jukema, J. W.; Klempfner, R.; Landmesser, U.; Schiele, F.; Sionis, A. | |
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases | 1-gen-2023 | De Carlo, M.; Schlager, O.; Mazzolai, L.; Brodmann, M.; Espinola-Klein, C.; Staub, D.; Aboyans, V.; Sillesen, H.; Debus, S.; Venermo, M.; Belch, J.; Ferrari, M.; De Caterina, R. | |
Declining trends of premature mortality from ischemic heart disease and regional differences in Italy from 2011 to 2017 | 1-gen-2023 | Zuin, M.; di Fusco, S. A.; De Caterina, R.; Roncon, L.; Rigatelli, G.; Colivicchi, F.; Bilato, C. | |
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications | 1-gen-2023 | Galli, M.; Franchi, F.; Rollini, F.; Ortega-Paz, L.; D'Amario, D.; De Caterina, R.; Mehran, R.; Gibson, C. M.; Angiolillo, D. J. | |
Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial | 1-gen-2023 | Shim, C. Y.; Seo, J.; Kim, Y. J.; Lee, S. H.; De Caterina, R.; Lee, S.; Hong, G. -R.; Lee, C. J.; Shin, D. -H.; Ha, J. -W.; Suh, Y. J.; Choi, J. Y.; Cho, I. -J.; Roh, Y. H. | |
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy | 1-gen-2023 | Madonna, Rosalinda; Moscato, Stefania; Cufaro, Maria Concetta; Pieragostino, Damiana; Mattii, Letizia; Del Boccio, Piero; Ghelardoni, Sandra; Zucchi, Riccardo; De Caterina, Raffaele | |
Factor XI inhibitors: cardiovascular perspectives | 1-gen-2023 | De Caterina, Raffaele; Prisco, Domenico; Eikelboom, John W | |
Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives | 1-gen-2023 | Corradi, Francesco; Masini, Gabriele; Bucciarelli, Tonino; DE CATERINA, Raffaele | |
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How | 1-gen-2023 | Liga, Riccardo; Colli, Andrea; Taggart, David P; Boden, William E; De Caterina, Raffaele | |
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis | 1-gen-2023 | Potere, N.; Garrad, E.; Kanthi, Y.; Di Nisio, M.; Kaplanski, G.; Bonaventura, A.; Connors, J. M.; De Caterina, R.; Abbate, A. | |
Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry | 1-gen-2023 | Schnabel, R. B.; Ameri, P.; Siller-Matula, J. M.; Diemberger, I.; Gwechenberger, M.; Pecen, L.; Manu, M. C.; Souza, J.; De Caterina, R.; Kirchhof, P. | |
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis | 1-gen-2023 | Galli, M; Benenati, S; Zito, A; Capodanno, D; Zoccai, Gb; Ortega-Paz, L; Iaconelli, A; D'Amario, D; Porto, I; Burzotta, F; Trani, C; De Caterina, R; Gaudino, M; Escaned, J; Angiolillo, Dj; Crea, F | |
Reversal agents for current and forthcoming direct oral anticoagulants | 1-gen-2023 | van Es, N.; De Caterina, R.; Weitz, J. I. |